NYSE:A - Agilent Technologies Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $69.11 -0.19 (-0.27 %) (As of 05/19/2019 04:00 PM ET)Previous Close$69.11Today's Range$68.19 - $69.8752-Week Range$60.42 - $82.27Volume3.94 million shsAverage Volume2.71 million shsMarket Capitalization$21.94 billionP/E Ratio24.77Dividend Yield0.95%Beta1.33 ProfileAnalyst RatingsChartDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies. The Diagnostics and Genomics segment provides reagents, instruments, software, and consumables; arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression profiling, as well as sequencing target enrichment, genetic data management, and interpretation support software; and equipment focused on production of synthesized oligonucleotides for use as active pharmaceutical ingredients. The Agilent CrossLab segment offers GC and LC columns, sample preparation products, custom chemistries, and various laboratory instrument supplies; and startup, operational, training, compliance support, and software as a service, as well as asset management and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was founded in 1999 and is headquartered in Santa Clara, California. Receive A News and Ratings via Email Sign-up to receive the latest news and ratings for A and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NYSE Industry Analytical instruments Sub-IndustryLife Sciences Tools & Services SectorComputer and Technology Current SymbolNYSE:A Previous Symbol CUSIP00846U10 CIK1090872 Webwww.agilent.com Phone408-345-8886Debt Debt-to-Equity Ratio0.35 Current Ratio3.41 Quick Ratio2.79Price-To-Earnings Trailing P/E Ratio24.77 Forward P/E Ratio22.66 P/E Growth1.93 Sales & Book Value Annual Sales$4.91 billion Price / Sales4.47 Cash Flow$3.5046 per share Price / Cash Flow19.72 Book Value$16.14 per share Price / Book4.28Profitability EPS (Most Recent Fiscal Year)$2.79 Net Income$316 million Net Margins22.25% Return on Equity19.71% Return on Assets10.91%Miscellaneous Employees14,800 Outstanding Shares317,520,000Market Cap$21.94 billion Next Earnings Date8/13/2019 (Estimated) OptionableOptionable Agilent Technologies (NYSE:A) Frequently Asked Questions What is Agilent Technologies' stock symbol? Agilent Technologies trades on the New York Stock Exchange (NYSE) under the ticker symbol "A." How often does Agilent Technologies pay dividends? What is the dividend yield for Agilent Technologies? Agilent Technologies announced a quarterly dividend on Thursday, March 21st. Stockholders of record on Tuesday, April 2nd will be given a dividend of $0.164 per share on Wednesday, April 24th. This represents a $0.66 dividend on an annualized basis and a dividend yield of 0.95%. The ex-dividend date is Monday, April 1st. View Agilent Technologies' Dividend History. How will Agilent Technologies' stock buyback program work? Agilent Technologies declared that its board has authorized a share repurchase program on Monday, November 19th 2018, which authorizes the company to repurchase $1,750,000,000.00 in shares, according to EventVestor. This repurchase authorization authorizes the company to purchase up to 8.8% of its shares through open market purchases. Shares repurchase programs are typically an indication that the company's leadership believes its stock is undervalued. How were Agilent Technologies' earnings last quarter? Agilent Technologies Inc (NYSE:A) announced its quarterly earnings results on Tuesday, May, 14th. The medical research company reported $0.71 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.72 by $0.01. The medical research company had revenue of $1.24 billion for the quarter, compared to analysts' expectations of $1.27 billion. Agilent Technologies had a return on equity of 19.71% and a net margin of 22.25%. Agilent Technologies's revenue for the quarter was up 2.7% on a year-over-year basis. During the same period in the previous year, the firm posted $0.65 EPS. View Agilent Technologies' Earnings History. When is Agilent Technologies' next earnings date? Agilent Technologies is scheduled to release their next quarterly earnings announcement on Tuesday, August 13th 2019. View Earnings Estimates for Agilent Technologies. What guidance has Agilent Technologies issued on next quarter's earnings? Agilent Technologies updated its FY19 earnings guidance on Tuesday, May, 14th. The company provided earnings per share (EPS) guidance of $3.03-3.07 for the period, compared to the Thomson Reuters consensus EPS estimate of $3.07. The company issued revenue guidance of $5.09-5.13 billion, compared to the consensus revenue estimate of $5.19 billion.Agilent Technologies also updated its FY 2019 guidance to $3.03-3.07 EPS. What price target have analysts set for A? 13 brokerages have issued 12 month price targets for Agilent Technologies' shares. Their predictions range from $82.00 to $92.00. On average, they expect Agilent Technologies' stock price to reach $86.4545 in the next year. This suggests a possible upside of 25.1% from the stock's current price. View Analyst Price Targets for Agilent Technologies. What is the consensus analysts' recommendation for Agilent Technologies? 13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Agilent Technologies in the last year. There are currently 2 hold ratings and 11 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Agilent Technologies. What are Wall Street analysts saying about Agilent Technologies stock? Here are some recent quotes from research analysts about Agilent Technologies stock: 1. According to Zacks Investment Research, "Agilent reported weak fiscal second-quarter results due to slowing global demand in small molecule Pharma and softness in the China Food market. However, Agilent saw notable improvement across its other product lines. Moreover, its strengthening position in Americas, China and Europe remain the key growth drivers. Additionally, the company’s decision to wind up its underperforming businesses is benefiting its core operations. Further, the company’s focus on aligning investments towards more attractive growth avenues and innovative high-margin product launches are major positives. Notably, the stock has underperformed the industry it belongs to over a year. However, macro weakness in some regions and unfavorable foreign exchange remain concerns. Also, higher expenses are making margin expansion difficult for the company." (5/16/2019) 2. Barclays PLC analysts commented, "We think Agilent delivered a solid FY1Q19 print last night, featuring a modest top line beat which was leveraged into a 6% EPS beat ($0.76 vs. our $0.72 forecast). Consistent trends help improve our conviction in the thesis heading into FY2019. Organic growth of 6% in the quarter came in 1.2% better than our expectations and guidance. Growth was solid, although less broad-based than last quarter – which we view as understandable in the context of tough quarterly comps. Notably, DGG posted 13% organic growth while ACG delivered 10% organic growth. The capital equipment driven LSAG division posted just" 1% organic growth, but on an 11% quarterly comp. From an end market perspective, we think results hit the mark across customer classes and geographies. Pharma & Sales) posted 10% core growth." (2/21/2019) Has Agilent Technologies been receiving favorable news coverage? Press coverage about A stock has been trending somewhat positive on Sunday, InfoTrie Sentiment reports. The research group ranks the sentiment of press coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Agilent Technologies earned a coverage optimism score of 1.9 on InfoTrie's scale. They also assigned press coverage about the medical research company a news buzz of 4.0 out of 10, indicating that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the near term. Who are some of Agilent Technologies' key competitors? Some companies that are related to Agilent Technologies include Illumina (ILMN), Mettler-Toledo International (MTD), Waters (WAT), PerkinElmer (PKI), Bio-Rad Laboratories (BIO.B), Bio-Rad Laboratories (BIO), Bruker (BRKR), Coherent (COHR), Horiba (HRIBF), Pacific Biosciences of California (PACB), Accelerate Diagnostics (AXDX), Fluidigm (FLDM), Quanterix (QTRX), Eyepoint Pharmaceuticals (EYPT) and Harvard Bioscience (HBIO). What other stocks do shareholders of Agilent Technologies own? Based on aggregate information from My MarketBeat watchlists, some companies that other Agilent Technologies investors own include Alibaba Group (BABA), Netflix (NFLX), Boeing (BA), NVIDIA (NVDA), AbbVie (ABBV), AT&T (T), Celgene (CELG), Intel (INTC), Applied Materials (AMAT) and Advanced Micro Devices (AMD). Who are Agilent Technologies' key executives? Agilent Technologies' management team includes the folowing people: Mr. Michael R. McMullen, CEO, Pres & Director (Age 58)Mr. Robert W. McMahon, Sr. VP & CFO (Age 50)Mr. Dominique P. Grau, Sr. VP of HR (Age 60)Mr. Mark Doak, Sr. VP (Age 64)Mr. Jacob Thaysen, Sr. VP (Age 44) Who are Agilent Technologies' major shareholders? Agilent Technologies' stock is owned by a number of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (7.86%), Wellington Management Group LLP (2.66%), OppenheimerFunds Inc. (2.63%), Artisan Partners Limited Partnership (1.84%), FMR LLC (1.77%) and American Century Companies Inc. (1.55%). Company insiders that own Agilent Technologies stock include Boon Hwee Koh, Didier Hirsch, Dominique Grau, Heidi Fields, Jacob Thaysen, James Cullen, Mark Doak, Michael R Mcmullen, Michael Tang, Patrick G Hagan, Patrick Kaltenbach, Paul N Clark and Rodney Gonsalves. View Institutional Ownership Trends for Agilent Technologies. Which institutional investors are selling Agilent Technologies stock? A stock was sold by a variety of institutional investors in the last quarter, including Marshall Wace LLP, Wells Fargo & Company MN, Findlay Park Partners LLP, Morgan Stanley, AQR Capital Management LLC, Factory Mutual Insurance Co., Candriam Luxembourg S.C.A. and Natixis. Company insiders that have sold Agilent Technologies company stock in the last year include Boon Hwee Koh, Dominique Grau, Heidi Fields, Mark Doak, Michael R Mcmullen, Michael Tang, Paul N Clark and Rodney Gonsalves. View Insider Buying and Selling for Agilent Technologies. Which institutional investors are buying Agilent Technologies stock? A stock was purchased by a variety of institutional investors in the last quarter, including SEI Investments Co, American Century Companies Inc., Man Group plc, Geode Capital Management LLC, Royal London Asset Management Ltd., MERIAN GLOBAL INVESTORS UK Ltd, Renaissance Technologies LLC and Cookson Peirce & Co. Inc.. View Insider Buying and Selling for Agilent Technologies. How do I buy shares of Agilent Technologies? Shares of A can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Agilent Technologies' stock price today? One share of A stock can currently be purchased for approximately $69.11. How big of a company is Agilent Technologies? Agilent Technologies has a market capitalization of $21.94 billion and generates $4.91 billion in revenue each year. The medical research company earns $316 million in net income (profit) each year or $2.79 on an earnings per share basis. Agilent Technologies employs 14,800 workers across the globe. What is Agilent Technologies' official website? The official website for Agilent Technologies is http://www.agilent.com. How can I contact Agilent Technologies? Agilent Technologies' mailing address is 5301 STEVENS CREEK BLVD, SANTA CLARA CA, 95051. The medical research company can be reached via phone at 408-345-8886 or via email at [email protected] MarketBeat Community Rating for Agilent Technologies (NYSE A)Community Ranking: 3.1 out of 5 ( )Outperform Votes: 674 (Vote Outperform)Underperform Votes: 427 (Vote Underperform)Total Votes: 1,101MarketBeat's community ratings are surveys of what our community members think about Agilent Technologies and other stocks. Vote "Outperform" if you believe A will outperform the S&P 500 over the long term. Vote "Underperform" if you believe A will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 5/19/2019 by MarketBeat.com StaffFeatured Article: Different Options Trading Strategies Receive Analysts' Upgrades and Downgrades Daily Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.